Animal StudyResults in animals only. May or may not translate to humans.Published: April 23, 2026
Sympathetic Nerve Signals May Contribute to Psoriasis Inflammation
Researchers studied how sympathetic nerve signals affect psoriasis inflammation in mice and human skin cells. They found that these signals may contribute to inflammation by recruiting neutrophils, a type of immune cell. The study suggests that sympathetic nerve signals may play a role in psoriasis, but more research is needed to confirm this.
Why it matters: Understanding the role of sympathetic nerve signals in psoriasis may help researchers develop new treatments for this common skin condition.
This study was conducted in mice and human skin cells in a lab, and the findings may not apply to humans. Further research is needed to confirm these results and explore their relevance to human psoriasis.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Salicylic AcidPublished: April 21, 2026
Common Medications May Cause Skin Reactions to Sunlight
Researchers studied how 10 commonly prescribed medications affect human skin when exposed to sunlight. They found that some medications may cause skin redness and darkening, but the effects varied greatly between individuals. The study suggests that more standardised methods are needed to assess the impact of medications on skin.
Why it matters: This study may help us better understand how certain medications interact with sunlight and affect the skin, which could lead to improved skincare and sun protection strategies.
A small pilot study with 12 healthy volunteers, limited to a specific set of medications and skin types. The study's findings may not be generalisable to other populations or medications.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Published: April 20, 2026
Rare Skin Condition Mimics GVHD in Transplant Patient
Researchers studied a rare skin condition called eccrine squamous syringometaplasia (ESS) in a 3-year-old boy who had undergone a transplant. The condition caused a skin rash that looked like a different condition called acute cutaneous graft-versus-host disease (GVHD). A skin biopsy revealed that the rash was actually ESS, not GVHD. The rash went away with topical corticosteroids.
Why it matters: Understanding ESS can help doctors distinguish it from GVHD and avoid unnecessary treatment changes.
This case report is based on a single patient and does not provide a large sample size for comparison.
Animal StudyResults in animals only. May or may not translate to humans.Published: April 15, 2026
Zerumbone from Ginger Plant May Help Soothe Atopic Dermatitis
Researchers studied zerumbone, a compound from the Zingiber zerumbet plant, to see if it could help with atopic dermatitis. They found that it may reduce inflammation and improve skin barrier function in lab experiments and animal studies. However, more research is needed to confirm these findings.
Why it matters: Understanding natural compounds that may help with atopic dermatitis could lead to new, more accessible treatment options.
This study was conducted in lab experiments and animal models, and more research is needed to confirm its findings in humans. The study's results may not translate directly to human skin conditions.
Animal StudyResults in animals only. May or may not translate to humans.Published: April 12, 2026
Perilla oil-based nanoemulsions may help with psoriasis symptoms
Researchers developed a new type of skin treatment using perilla essential oil. They found that this treatment may help reduce inflammation and improve skin health in people with psoriasis. However, more studies are needed to confirm these findings.
Why it matters: This study may contribute to the development of new, natural treatments for psoriasis.
This study was conducted in mice and in lab experiments, so its results may not directly apply to humans. Further research is needed to confirm these findings.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Published: April 7, 2026
Exosome-based treatment may help with androgenetic alopecia
Researchers studied a new treatment for androgenetic alopecia, a condition causing hair thinning, using a combination of exosomes, plasma, and sonophoresis. A small study found that this treatment may improve hair density, hair shaft diameter, and scalp health. However, more research is needed to confirm these findings.
Why it matters: This study may contribute to the development of new treatments for androgenetic alopecia, a common condition affecting many people.
This study had a small sample size of 25 participants and was a pilot study, meaning it was not a controlled trial. More research is needed to confirm the findings and to isolate the contribution of the delivery modalities.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Published: April 1, 2026
Avulsed Nasal Skin May Help in Nasal Reconstruction After Trauma
Researchers studied a unique case where a man's avulsed nasal skin was repurposed for reconstruction after a fall. The skin was carefully prepared and secured, and it survived without complications. The study suggests that avulsed nasal skin can be used for reconstruction when properly prepared.
Why it matters: This study may help improve understanding of nasal skin reconstruction and its challenges.
A single case study with a small sample size, and the study's findings may not be generalizable to other situations.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: April 1, 2026
Radiofrequency Microneedling May Help Improve Facial Appearance
Researchers studied radiofrequency microneedling for facial rejuvenation and found that it may improve skin texture and appearance. Participants reported high satisfaction with the treatment, but more research is needed to confirm these findings. The treatment was generally well-tolerated, with mild side effects.
Why it matters: This study may help skincare professionals and individuals understand the potential benefits and limitations of radiofrequency microneedling for facial rejuvenation.
This systematic review included 22 studies with 558 participants, but the findings may not be generalizable to all individuals. The review did not assess the long-term effects of radiofrequency microneedling.
Animal StudyResults in animals only. May or may not translate to humans.Published: March 30, 2026
Pozaconazole May Help Manage Refractory Dermatophytosis in Dogs
Researchers studied a case of a dog with a persistent fungal skin infection called dermatophytosis. The dog didn't respond to standard treatments, so the researchers tried a different antifungal medication called posaconazole. They found that the dog's symptoms improved without any side effects.
Why it matters: This study may help veterinarians develop new treatment strategies for dogs with refractory dermatophytosis, a condition that can be contagious to humans.
This was a single case study in a dog, and the results may not be generalizable to other animals or humans. The study was conducted in a veterinary setting, not a lab, but the treatment was based on antifungal susceptibility testing (AFST).
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: March 24, 2026
Sevoflurane May Help Reduce Pain in Chronic Wounds
Researchers studied the use of sevoflurane as a local analgesic for managing pain in chronic or hard-to-heal wounds. They found that sevoflurane may reduce pain within minutes and last for hours, with minimal reported side effects. However, more research is needed to confirm its safety and effectiveness.
Why it matters: Understanding the potential benefits of sevoflurane for wound pain management could lead to improved treatment options for people with chronic wounds.
The review is based on 21 studies, but more high-quality research is needed to solidify the efficacy and safety of topically administered sevoflurane. The studies included various types, but the review did not specify the sample size or duration of the studies.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Published: March 19, 2026
Rare Skin Infection May Spread to Other Areas
Researchers reported a case of a rare skin infection caused by a fungus called Trichophyton rubrum. This fungus is usually harmless but can cause problems in people with weakened immune systems. In this case, the infection spread to other areas of the body and caused multiple ulcers and abscesses.
Why it matters: This case study may help dermatologists better understand how this rare infection can progress and how to treat it.
This study is a case report and involved a single patient, so the findings may not be representative of all cases. The patient had a history of immunosuppression, which may have contributed to the severity of the infection.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Published: March 19, 2026
Tirbanibulin 1% May Help Treat Actinic Keratosis
A small study in Spain and Italy looked at how well tirbanibulin 1% worked for patients with actinic keratosis, a skin condition often caused by sun exposure. Researchers found that patients and doctors were generally satisfied with the treatment and reported good results. However, more research is needed to confirm these findings.
Why it matters: This study may help us better understand how to treat actinic keratosis, a common skin condition that can be a sign of skin cancer.
This study was conducted in a small group of patients (n=328) in Spain and Italy, and the results may not be generalizable to other populations. The study had a short duration of 57 days, and more research is needed to confirm the long-term effectiveness and safety of tirbanibulin 1%.